A Molassiotis1, L Brunton2, J Hodgetts3, A C Green4, V L Beesley5, C Mulatero6, J A Newton-Bishop7, P Lorigan3. 1. School of Nursing, The Hong Kong Polytechnic University, Hong Kong; School of Nursing, Midwifery and Social Work, University of Manchester, Manchester. Electronic address: alex.molasiotis@polyu.edu.hk. 2. School of Nursing, Midwifery and Social Work, University of Manchester, Manchester. 3. Christie NHS Foundation Trust, Manchester. 4. Institute of Inflammation and Repair, University of Manchester, Manchester, UK; Cancer and Population Studies Group, QIMR Berghofer Medical Research Institute, Brisbane. 5. Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. 6. St James's Institute of Oncology, Leeds. 7. Institute of Cancer Studies and Pathology, University of Leeds, Leeds, UK.
Abstract
BACKGROUND: Knowledge about supportive care needs in patients with cutaneous invasive melanoma is scarce. We examined the unmet needs of melanoma patients treated with surgery and factors associated with these needs to assist health professionals identify areas needing clinical attention. PATIENTS AND METHODS: Cross-sectional multisite survey of UK patients ascertained 3 months to 5 years after complete resection of stage I-III cutaneous melanoma. Participants completed the following validated questionnaires: Supportive Care Needs Survey (SCNS-SF34 with melanoma module), Hospital Anxiety and Depression Scale and 51-item Functional Assessment of Cancer Therapy-Melanoma quality-of-life scale. RESULTS: A total of 472 participants were recruited [319 (67%) clinical stage I-II). Mean age was 60 years (standard deviation = 14) and 255 (54%) were female. One hundred and twenty-three (27%) participants reported at least one unmet need (mostly 'low' level). The most frequently reported unmet needs were fears of cancer returning (n = 138, 29%), uncertainty about the future (n = 119, 25%), lack of information about risk of recurrence (n = 112, 24%) and about possible outcomes if melanoma were to spread (n = 91, 20%). One hundred and thirty-eight (29%) participants reported anxiety and 51 (11%) depression at clinical or subclinical levels. Patients with nodal disease had a significantly higher level of unmet supportive care needs (P < 0.001) as did patients with anxiety or depression (P < 0.001). Key correlates of the total SCNS-SF34 score for unmet supportive care needs were younger age (odds ratio, OR = 2.23, P < 0.001) and leaving school early (OR = 4.85, P < 0.001), while better emotional (OR = 0.89, P < 0.001) and social well-being (OR = 0.91, P < 0.001) were linked with fewer unmet needs. Neither patients' sex nor tumour thickness was associated with unmet needs. CONCLUSIONS: Around a quarter of melanoma patients may have unmet support needs in the mid to long term after primary treatment. In particular, patients who are younger, less educated, distressed or socially isolated could benefit from more support.
BACKGROUND: Knowledge about supportive care needs in patients with cutaneous invasive melanoma is scarce. We examined the unmet needs of melanoma patients treated with surgery and factors associated with these needs to assist health professionals identify areas needing clinical attention. PATIENTS AND METHODS: Cross-sectional multisite survey of UK patients ascertained 3 months to 5 years after complete resection of stage I-III cutaneous melanoma. Participants completed the following validated questionnaires: Supportive Care Needs Survey (SCNS-SF34 with melanoma module), Hospital Anxiety and Depression Scale and 51-item Functional Assessment of Cancer Therapy-Melanoma quality-of-life scale. RESULTS: A total of 472 participants were recruited [319 (67%) clinical stage I-II). Mean age was 60 years (standard deviation = 14) and 255 (54%) were female. One hundred and twenty-three (27%) participants reported at least one unmet need (mostly 'low' level). The most frequently reported unmet needs were fears of cancer returning (n = 138, 29%), uncertainty about the future (n = 119, 25%), lack of information about risk of recurrence (n = 112, 24%) and about possible outcomes if melanoma were to spread (n = 91, 20%). One hundred and thirty-eight (29%) participants reported anxiety and 51 (11%) depression at clinical or subclinical levels. Patients with nodal disease had a significantly higher level of unmet supportive care needs (P < 0.001) as did patients with anxiety or depression (P < 0.001). Key correlates of the total SCNS-SF34 score for unmet supportive care needs were younger age (odds ratio, OR = 2.23, P < 0.001) and leaving school early (OR = 4.85, P < 0.001), while better emotional (OR = 0.89, P < 0.001) and social well-being (OR = 0.91, P < 0.001) were linked with fewer unmet needs. Neither patients' sex nor tumour thickness was associated with unmet needs. CONCLUSIONS: Around a quarter of melanoma patients may have unmet support needs in the mid to long term after primary treatment. In particular, patients who are younger, less educated, distressed or socially isolated could benefit from more support.
Authors: Zoe Stamataki; L Brunton; P Lorigan; A C Green; J Newton-Bishop; A Molassiotis Journal: Support Care Cancer Date: 2014-09-05 Impact factor: 3.603
Authors: T P Hanna; T Baetz; J Xu; Q Miao; C C Earle; Y Peng; C M Booth; T M Petrella; D R McKay; P Nguyen; H Langley; E Eisenhauer Journal: Curr Oncol Date: 2017-12-20 Impact factor: 3.677
Authors: Zoe Rogers; Faye Elliott; Nadine A Kasparian; D Timothy Bishop; Jennifer H Barrett; Julia Newton-Bishop Journal: Melanoma Res Date: 2016-10 Impact factor: 3.599
Authors: Vanessa L Beesley; B Mark Smithers; Peter O'Rourke; Monika Janda; Kiarash Khosrotehrani; Adèle C Green Journal: Support Care Cancer Date: 2016-08-25 Impact factor: 3.603